hotspot -WSS

hotspot

author：entertainment 2025-09-30 20:34:47 - browse：25618

Adam's take main illustration — Molly Ferguson/STAT

Hello! Some takes and thoughts on Gilead’s Trodelvy troubles, Elevation Oncology’s surprising rise, and Kura Oncology’s “wall-crossing” stock sale.

Gilead needs Arcellx more than ever

The clinical trial setback for Trodelvy in non-small cell lung cancer reported by Gilead Sciences on Monday was another dose of bad news for the company’s oncology business. Strategically, does it make sense for Gilead to invest even more in antibody-drug conjugates like Trodelvy, where its lackluster profile and increased competition overall makes winning seem unlikely? Or, should Gilead double down on its Kite division and CAR-T cell therapy — the type of cancer treatments where it truly excels?

If the answers to those questions are no and yes (I lean that way), then Gilead’s current partnership with Arcellx, which is developing a BCMA-targeted CAR-T therapy for multiple myeloma, becomes a lot more important.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： It's time to take a new tack for treating Alzheimer's

hotspot

WSS

Why psychiatrists like me stop taking insurance

Hey, doctors: Don't be no

Why psychiatrists like me stop taking insurance

The biotech scorecard for Q1: 17 stock

Biden White House, tech companies launch new safeguards around emerging AI technology

A new deal aims to ramp up use of AI in rehab care decisions

leisure time

hotspot

Gilead needs Arcellx more than ever

leisure time

BioMarin wins approval for gene therapy to treat hemophilia A

The biotech scorecard for Q1: 17 stock

The cancer drug shortage isn’t new — and neither are the solutions

The FDA must approve intranasal treatments for anaphylaxis

Supreme Court strikes down use of affirmative action

Feng Zhang CRISPR delivery startup lays off quarter of staff

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

Medical leaders decry Supreme Court decision on affirmative action

It's time to take a new tack for treating Alzheimer's

hotspot

White House finalizes ITC's import ban of latest Apple Watches

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

3 medical device trends to watch in 2024

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

GSK Flovent asthma inhalers replaced by authorized generics

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

leisure time

hotspot

focus

hotspot